Mednovation is very pleased to announce that it has entered into a cooperation agreement with Life Science Intelligence, Inc. (“LSI”) to promote the parties to the Medtech industry worldwide, and to cooperate with each other to support development and innovation in the Chinese Medtech market.
Under the agreed arrangement, which is effective as of this release, Mednovation shall be the preferred partner of LSI for its partnering events, seminars, market intelligence products, research services and other initiatives in China. Mednovation will support LSI for its major conferences in overseas countries, such as the 2023 LSI Emerging Medtech Summit in Dana Point, California (LSI USA ’23). The parties will also work together to expand LSI’s ecosystem to include partnering events curated and hosted specifically for Asian markets, including China.
William Jin, partner of Mednovation, said: “We are happy to build up a strategic relation with LSI. I believe the cooperation between the two parties will greatly help us and the members of Mednovation to access international markets and resources. We can also help LSI to further explore the Chinese market.”
Scott Pantel, CEO of LSI, said: China’s ecosystem presents a tremendous opportunity to advance Medtech innovation and continue our efforts towards saving patient lives and improving the standard of care globally. With our industry partnering events and market intelligence services, we support Medtech leaders in global markets. We are excited to take another step in advancing our global reach as we begin our transformative entry into China and engage their active Medtech innovation ecosystem.”
